CurrentRheuma
Get Weekly

CurrentRheuma coverage · page 7 of 15

Annals of the Rheumatic Diseases

Briefs 241–280 of 596 CurrentRheuma has covered from this journal, newest publication first

Latest from Annals of the Rheumatic Diseases

All coverage, newest first

  1. Ann Rheum Dis

    Mitochondria-centred metabolomic map of inclusion body myositis: sex-specific alterations in central carbon metabolism

    Mechanistic studyMyositis

  2. Ann Rheum Dis

    Variants in the DDX6-CXCR5 autoimmune disease risk locus influence the regulatory network in immune cells and salivary gland

    Mechanistic studySjögren's & overlap

  3. Ann Rheum Dis

    Genome-wide association study in chondrocalcinosis reveals ENPP1 as a candidate therapeutic target in calcium pyrophosphate deposition disease

    Research articleGout & crystals

  4. Ann Rheum Dis

    CD4+ tissue-resident memory Th17 cells are a major source of IL-17A in Spondyloarthritis synovial tissue

    Mechanistic studySpondyloarthritis & PsA

  5. Ann Rheum Dis

    Remote monitoring or patient-initiated care in axial spondyloarthritis: a 3-armed randomised controlled noninferiority trial

    Randomized controlled trialSpondyloarthritis & PsA

  6. Ann Rheum Dis

    Spatial multiomics decipher fibroblast–macrophage dynamics in systemic sclerosis

    Mechanistic studySystemic sclerosis

  7. Ann Rheum Dis

    Treating juvenile dermatomyositis to target: Paediatric Rheumatology European Society/Childhood Arthritis and Rheumatology Research Alliance-endorsed recommendations from an international task force

    Guideline or statementPediatric

  8. Ann Rheum Dis

    Identification and validation of interferon-driven gene signature as a predictor of response to methotrexate in juvenile idiopathic arthritis

    Diagnostic or prognostic studyPediatric

  9. Ann Rheum Dis

    Development of salivary gland organoids derived from patient biopsies: a functional model of Sjögren’s disease

    Mechanistic studySjögren's & overlap

  10. Ann Rheum Dis

    Disease-modifying antirheumatic drug–free remission in psoriatic arthritis: is it attainable and sustainable? A large longitudinal study

    Cohort studySpondyloarthritis & PsA

  11. Ann Rheum Dis

    Pulmonary arterial hypertension in adults with Still’s disease: another pulmonary manifestation associated with HLA-DRB1*15

    Case-control studyAutoinflammatory & rare

  12. Ann Rheum Dis

    Radiographic structural damage in axial spondyloarthritis: is there a preferred way to quantify progression over time? Comparison of blinded versus unblinded mSASSS scoring

    Cohort studySpondyloarthritis & PsA

  13. Ann Rheum Dis

    New IgG and IgA autoantibody specificities against DNA-binding and RNA-binding proteins discriminate systemic lupus erythematosus from health and non-lupus autoimmunity–could anti-LIN28A enhance precision in diagnostics?

    Diagnostic or prognostic studyLupus & APS

  14. Ann Rheum Dis

    Anti-TFAM antibodies link mitochondrial damage with antiphospholipid syndrome and thrombosis in SLE

    Cross-sectional studyLupus & APS

  15. Ann Rheum Dis

    Novel IgG and IgA autoantibodies validated in two independent cohorts are associated with disease activity and determine organ manifestations in systemic lupus erythematosus: implications for anti-LIN28A, anti-HMGN5, anti-IRF5, and anti-TGIF1

    Cross-sectional studyLupus & APS

  16. Ann Rheum Dis

    Time-independent disease state identification defines distinct trajectories determined by localised vs systemic inflammation in patients with early rheumatoid arthritis

    Cohort studyRA

  17. Ann Rheum Dis

    Epitopes targeted by autoantibodies in presymptomatic individuals predict early rheumatoid arthritis

    Diagnostic or prognostic studyRA

  18. Ann Rheum Dis

    Enhanced B cell and complement cascade gene signatures in patients with neuropsychiatric systemic lupus erythematosus

    Mechanistic studyLupus & APS

  19. Ann Rheum Dis

    Systematic review and independent validation of genetic factors of radiographic outcome in rheumatoid arthritis identifies a genome-wide association with CARD9

    Meta-analysisRA

  20. Ann Rheum Dis

    Satisfaction with telemedicine versus in-person visits in rheumatology: a noninferiority randomised controlled trial

    Randomized controlled trialAcross diseases

  21. Ann Rheum Dis

    EULAR/ACR risk stratification criteria for development of rheumatoid arthritis in the risk stage of arthralgia

    Diagnostic or prognostic studyRA

  22. Ann Rheum Dis

    Janus kinase inhibitors enhance prostanoid biosynthesis in human whole blood in vitro: implications for cardiovascular side effects and prevention strategies

    Mechanistic studyLupus & APS

  23. Ann Rheum Dis

    A cross-sectional observational study of patients with sicca with salivary autoantibodies defines a potential new phenotype of Sjögren’s disease

    Cross-sectional studySjögren's & overlap

  24. Ann Rheum Dis

    Adalimumab serum concentration to choose a subsequent biological DMARD in patients with rheumatoid arthritis (ADDORA-switch): results of a blinded randomised test-treatment trial

    Randomized controlled trialRA

  25. Ann Rheum Dis

    EULAR recommendations for use of antirheumatic drugs in reproduction, pregnancy, and lactation: 2024 update

    Guideline or statementAcross diseases

  26. Ann Rheum Dis

    The Prospective Registry of MyositIS (PROMIS): I. Next-generation sequencing identifies HLA-DQA1 as a novel genetic risk of anti-MDA5 antibody-positive dermatomyositis

    Diagnostic or prognostic studyMyositis

  27. Ann Rheum Dis

    Antirheumatic drugs in reproduction, pregnancy, and lactation: a systematic literature review informing the 2024 update of the EULAR recommendations

    Meta-analysisAcross diseases

  28. Ann Rheum Dis

    Chasing the target: reports from the Advances in Targeted Therapies meeting, 2024

    Research articleAcross diseases

  29. Ann Rheum Dis

    Efficacy and safety of izokibep in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 study

    Randomized controlled trialSpondyloarthritis & PsA

  30. Ann Rheum Dis

    Certolizumab pegol to prevent adverse pregnancy outcomes in patients with antiphospholipid syndrome and lupus anticoagulant (IMPACT): results of a prospective, single-arm, open-label, phase 2 trial

    Cohort studyLupus & APS

  31. Ann Rheum Dis

    EULAR/PReS endorsed recommendations for the management of familial Mediterranean fever (FMF): 2024 update

    Guideline or statementAutoinflammatory & rare

  32. Ann Rheum Dis

    Treatment with methotrexate plus oral prednisolone versus triple therapy (methotrexate/sulfasalazine/hydroxychloroquine) plus intra-articular glucocorticoids in early rheumatoid arthritis: a prespecified nonrandomised subgroup analysis of clinical and radiographic data at 48 weeks from the NORD-STAR trial's conventional treatment arm

    Secondary analysisRA

  33. Ann Rheum Dis

    Diagnostic delay and less intensive therapy for people with psoriatic arthritis compared with rheumatoid arthritis: a study nested within an English and Welsh audit data set

    Cohort studySpondyloarthritis & PsA

  34. Ann Rheum Dis

    Efficacy, safety and tolerability of GSK3858279, an anti-CCL17 monoclonal antibody and analgesic, in healthy volunteers and patients with knee osteoarthritis pain: a phase I, randomised, double-blind, placebo-controlled, proof-of-mechanism and proof-of-concept study

    Randomized controlled trialOsteoarthritis

  35. Ann Rheum Dis

    Minimally invasive retrieval and characterisation of tenosynovial tissue in rheumatoid arthritis: a novel approach to study at-risk, active, and remission stages

    Mechanistic studyRA

  36. Ann Rheum Dis

    The role of multicriteria decision analysis in the development of candidate classification criteria for antisynthetase syndrome: analysis from the CLASS project

    Diagnostic or prognostic studyMyositis

  37. Ann Rheum Dis

    Evaluation of instruments assessing peripheral arthritis in spondyloarthritis: an analysis of the ASAS-PerSpA study

    Cross-sectional studySpondyloarthritis & PsA

  38. Ann Rheum Dis

    The IL-6 axis in vascular inflammation: effects of IL-6 receptor blockade on vascular lesions from patients with giant-cell arteritis

    Mechanistic studyVasculitis & PMR

  39. Ann Rheum Dis

    Expert consensus statement on the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: 2024 update

    Guideline or statementAcross diseases

  40. Ann Rheum Dis

    An interpretable machine learning approach for detecting psoriatic arthritis in a UK primary care psoriasis cohort using electronic health records from the Clinical Practice Research Datalink

    Diagnostic or prognostic studySpondyloarthritis & PsA

All 596 Briefs in ExploreShowing Briefs 241–280 of 596, newest first